Amaxa’s Nucleofector technology is a highly efficient non-viral method for transfection, based on two components: the Nucleofector device that delivers unique electrical parameters and Nucleofector kits that contain cell-type-specific Nucleofector solutions.
The electrical parameters of the Nucleofector are claimed to be different from other electroporation devices. Each electrical setting is displayed as a distinct program which has been adapted to the requirements of a particular cell type. Electrical parameters are preprogrammed into the Nucleofector, thus optimisation by the user is not necessary.
The device weighs 2.6 kg and is sized to fit under a sterile hood, suitable for sterile work with cells.
Phone: 1300 657508
Beckman Coulter Life Sciences Basophil Activation Test (BAT) for food allergy research
Beckman Coulter Life Sciences introduces its next-generation Basophil Activation Test (BAT) to...
TopoGEN Topoisomerase Assay Kits
TopoGEN provides innovative reagents and kits for topoisomerase research and mechanism-based drug...
Alamar Biosciences NULISAseq Mouse Panel 120 for protein biomarker analysis
The multiplex panel encompasses a wide selection of proteins essential for studying key...
Learn More
I am interested in Amaxa Nucleofector device.
Complete the form and a supplier representative will be in touch.
